Wednesday, March 12, 2025 8:19:34 AM
Shareholders
Mar. 12, 2025 7:59 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 12, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH)
Dear Shareholders,
I wanted to issue this brief letter to share a few updates. To start, it's important to note that there are no delays with the NIH or NSF grants. These grants were filed in advance of the January 6th deadline and as a result we are expecting answers in May possibly April. I also received notification that the review process for these grants will start in March. The NIH grant would allow Johns Hopkins University the ability to move forward with clinical trials of our smoke-free low dose dissolvable strip and allow CTT to create the first oral smoking cessation product in 40 years. Additionally, we added two people to the company to help with the NIH and NSF grants. They have extensive knowledge about our technology and have many years of experience with grants.
Mar. 12, 2025 7:59 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 12, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH)
Dear Shareholders,
I wanted to issue this brief letter to share a few updates. To start, it's important to note that there are no delays with the NIH or NSF grants. These grants were filed in advance of the January 6th deadline and as a result we are expecting answers in May possibly April. I also received notification that the review process for these grants will start in March. The NIH grant would allow Johns Hopkins University the ability to move forward with clinical trials of our smoke-free low dose dissolvable strip and allow CTT to create the first oral smoking cessation product in 40 years. Additionally, we added two people to the company to help with the NIH and NSF grants. They have extensive knowledge about our technology and have many years of experience with grants.
Recent CTTH News
- CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones • ACCESS Newswire • 12/30/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 04:45:46 PM
- CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics • ACCESS Newswire • 12/16/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2025 02:52:22 PM
